The impact of new tuberculosis diagnostics on transmission: why context matters.
about
Mathematical Modelling and Tuberculosis: Advances in Diagnostics and Novel TherapiesBridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-makingThe diagnostic performance of a single GeneXpert MTB/RIF assay in an intensified tuberculosis case finding survey among HIV-infected prisoners in MalaysiaAlignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for actionGlobal control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisModeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening.Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.Tuberculosis control in South African gold mines: mathematical modeling of a trial of community-wide isoniazid preventive therapy.Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.Use of Rapid, Point-of-Care Assays by Private Practitioners in Chennai, India: Priorities for Tuberculosis Diagnostic Testing.Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.Tuberculosis control in China: use of modelling to develop targets and policies.Improving Control of Tuberculosis in Low-Burden Countries: Insights from Mathematical Modeling.The patient impact of point-of-care vs. laboratory placement of Xpert(®) MTB/RIF.Is passive diagnosis enough? The impact of subclinical disease on diagnostic strategies for tuberculosis.Modeling the impact of alternative strategies for rapid molecular diagnosis of tuberculosis in Southeast Asia.Tuberculosis screening in high human immunodeficiency virus prevalence settings: turning promise into reality.Biosensors for Monitoring Airborne Pathogens.Impact of gyrB and eis Mutations in Improving Detection of Second-Line-Drug Resistance among Mycobacterium tuberculosis Isolates from Georgia.A proposed novel framework for monitoring and evaluation of the cascade of HIV-associated TB care at the health facility level.Impact of Point-of-care Xpert MTB/RIF on Tuberculosis Treatment Initiation: A Cluster Randomised Trial.Microscopic observation drug-susceptibility assay vs. Xpert® MTB/RIF for the diagnosis of tuberculosis in a rural African setting: a cost-utility analysis.Understanding the incremental value of novel diagnostic tests for tuberculosis.Strategies for halting the rise of multidrug resistant TB epidemics: assessing the effect of early case detection and isolation.Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study.Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic review.
P2860
Q26778117-4D4472C8-DB71-49EA-9D9E-E6B62A003395Q26778619-F8DB4B84-B14F-4647-BF3D-3761349A00A1Q28536945-1384DE22-0964-4D24-9D23-AD3F91A0AABCQ33576909-D95551A5-3441-42D5-BA70-0FDB75361328Q33926262-64C7A209-ED65-47AC-9480-69E0B9EC8079Q34395434-24438116-B420-4546-B259-58F096102109Q35023340-7AFAA406-D0FD-496F-937E-EF130DEBE3CCQ35069594-BD5A73EB-7E25-446D-B73A-B011521F8297Q35297467-097EB7DF-FFFC-4CA7-B167-90C5B1903EEEQ35686427-B8206B2C-7401-4633-9231-51CB096C5C9DQ36052716-53714147-BD0C-4DAB-9C70-80B94BDCF478Q36159840-374B38CC-6B54-426B-A828-F65F497412BCQ36211825-29D07965-A8CA-42F2-A338-0AD863044A89Q36859680-0F514BEB-DD52-4A82-B6BC-42C2A6B42A53Q36907330-083131DE-9528-47CD-BAE2-99D3802E61DAQ37070004-C9864C5D-48F8-4FDE-9071-4AB82A42CAABQ37380526-D4908B34-49D7-4E27-96B4-8DB922A72B1FQ37664997-AD7E9D46-3F11-4CF9-B815-BFB5F68A5D25Q38415697-C123D8F7-CD3B-47FA-90CF-148E92E9C959Q38718388-F3AE6EA2-D2BF-4E6F-BE5B-953448C7523CQ38821136-D77D62D3-994B-408C-B276-1C24833AC93BQ39172214-4536A58B-E853-41B6-A7DE-8B17035BD833Q39592738-F03E18F5-8071-476D-BF8C-523897572618Q40245352-EA5CC101-BDF7-4F12-A626-2CC4A741F195Q40275920-876402FC-BA65-48D3-8666-53048678585FQ51409194-9A1B3825-2CAA-4DC1-86B3-7803AE1DD11BQ55016083-936A483D-D68C-4863-AA87-10B0776B8DC2
P2860
The impact of new tuberculosis diagnostics on transmission: why context matters.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The impact of new tuberculosis diagnostics on transmission: why context matters.
@ast
The impact of new tuberculosis diagnostics on transmission: why context matters.
@en
type
label
The impact of new tuberculosis diagnostics on transmission: why context matters.
@ast
The impact of new tuberculosis diagnostics on transmission: why context matters.
@en
prefLabel
The impact of new tuberculosis diagnostics on transmission: why context matters.
@ast
The impact of new tuberculosis diagnostics on transmission: why context matters.
@en
P2093
P2860
P356
P1476
The impact of new tuberculosis diagnostics on transmission: why context matters.
@en
P2093
David Dowdy
Megan Murray
P2860
P304
P356
10.2471/BLT.11.101436
P407
P577
2012-07-16T00:00:00Z